LOUISVILLE, KY.— Feb. 27, 2019 – Humana members with chronic conditions who utilize specialty medications can rest assured their prescriptions will arrive safely and on-time thanks to a partnership between Humana Pharmacy, the mail-delivery pharmacy service of Humana Inc. (NYSE: HUM), and ParcelShield, the leader in technology-driven critical package protection.
According to the Centers for Disease Control and Prevention, chronic disease is a leading driver of health care costs – 6 in 10 Americans live with at least one chronic disease, such as heart disease, cancer, multiple sclerosis, and rheumatoid arthritis. Medication adherence is a big factor in managing these diseases and helping patients stay healthy.
Specialty medication can require refrigeration and must be cold pack shipped, which provides a 48-hour window for the medication to be shipped safely and securely.
By utilizing ParcelShield’s platform, Humana Pharmacy’s specialty dispensing team can proactively detect when there might be a problem with a specialty medication package’s delivery – such as weather and air travel issues – in order to prevent delays in members getting their therapy.
“By ensuring Humana members get their medication on-time and without delay, we can promote better medication adherence and, in turn, better outcomes for their health,” said Scott Greenwell, PharmD, Humana Pharmacy President. “Specialty medication is complex and partnering with ParcelShield allows us to predict and instantly handle issues to make the member experience seamless for this vulnerable population.”
“The partnership with Humana aligns perfectly with our core values because we both believe in putting the patient first,” said Doug Dawson, CEO of ParcelShield. “When you think about protecting critical packages, most companies focus on the package value or thermal sensitivity exposure. But for ParcelShield, we first focus on the patient outcome. We know that helping to get medications delivered on-time will increase medication adherence rates which is good for the patient and good for the industry.”